Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1

Fusobacterium nucleatum (F. nucleatum) is an oral anaerobe found to be enriched in colorectal cancer (CRC). Presence of F. nucleatum in CRC has been correlated with resistance to chemotherapy and poor prognosis. We previously demonstrated that the Fap2 outer-surface protein of F. nucleatum binds and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Gur, Chamutal, Maalouf, Naseem, Shhadeh, Amjad, Berhani, Orit, Singer, Bernhard B., Bachrach, Gilad, Mandelboim, Ofer
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492956/
https://ncbi.nlm.nih.gov/pubmed/31069151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1581531
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados